| 10.04.2024 13:05 | MXCT | Notice of Results | RNS |
| 03.04.2024 07:00 | MXCT | Total Voting Rights and Block Listing Return | RNS |
| 02.04.2024 15:19 | ORCA, CIZ, ANIC | TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian firms farmout | Alliance |
| 02.04.2024 13:05 | MXCT | Signing of Strategic Platform License | RNS |
| 02.04.2024 07:00 | MXCT | Exercise of options and PDMR dealing | RNS |
| 20.03.2024 10:16 | MXCT | Grant of Options, RSUs and PSUs and PDMR Dealing | RNS |
| 20.03.2024 10:05 | MXCT | Grant of Options, RSUs and PSUs and PDMR Dealing | RNS |
| 13.03.2024 11:54 | MXCT | IN BRIEF: MaxCyte loss widens in 2023 as core revenue declines 25% | Alliance |
| 13.03.2024 07:05 | MXCT | Filing of form 10-K for FY ended December 31, 2023 | RNS |
| 13.03.2024 07:00 | MXCT | Reports Q4 & FY 2023 Financial Results | RNS |
| 06.03.2024 08:58 | MXCT | TR-1: Notification of major holdings | RNS |
| 05.03.2024 20:43 | TMO, THR, OGN | EARNINGS: dotdigital eyes rosy future; Beeks Financial turns to profit | Alliance |
| 05.03.2024 16:06 | TCAP, TIFS, SYNT | UK earnings, trading statements calendar - next 7 days | Alliance |
| 05.03.2024 07:00 | MXCT | Preliminary FY Results & 2024 Guidance | RNS |
| 01.03.2024 17:57 | MXCT | Total Voting Rights | RNS |
| 29.02.2024 09:21 | MXCT | Exercise of options and PDMR dealing | RNS |
| 26.02.2024 07:00 | MXCT | TR-1: Notification of major holdings | RNS |
| 31.01.2024 07:00 | MXCT | Director/PDMR Shareholding | RNS |
| 30.01.2024 14:29 | MXCT | Holding(s) in Company | RNS |
| 30.01.2024 13:58 | MXCT | IN BRIEF: MaxCyte signs licencing deal with cell therapy company Wugen | Alliance |
| 30.01.2024 13:05 | MXCT | Signing of Strategic Platform License | RNS |
| 29.01.2024 17:56 | MXCT | IN BRIEF: MaxCyte chief scientific officer leaves firm | Alliance |
| 29.01.2024 16:52 | MXCT | TR-1: Notification of major holdings | RNS |
| 29.01.2024 07:00 | MXCT | Filing of Form 8-K | RNS |
| 23.01.2024 18:39 | MXCT, GSCU, SVML | TRADING UPDATES: Esken's Southend Airport faces further allegations | Alliance |
| 23.01.2024 13:05 | MXCT | Signing of Strategic Platform License | RNS |
| 09.01.2024 12:18 | MXCT | MaxCyte's strategic platform licences redeem otherwise modest results | Alliance |
| 09.01.2024 07:00 | MXCT | Preliminary Unaudited Q4 and FY 2023 Results | RNS |
| 05.01.2024 07:00 | MXCT | Grant of Options and PDMR Dealing | RNS |
| 03.01.2024 14:04 | MXCT | MaxCyte teams with Singapore-based Lion to support TCR-T cell work | Alliance |
| 03.01.2024 13:05 | MXCT | Signing of Strategic Platform License | RNS |
| 02.01.2024 09:23 | MXCT | Total Voting Rights | RNS |
| 02.01.2024 07:00 | MXCT | Confirmation of Board change | RNS |
| 29.12.2023 07:00 | MXCT | Exercise of options and PDMR dealing | RNS |
| 12.12.2023 15:56 | MXCT, TM1, ALL | TRADING UPDATES: Technology Minerals identifies lithium at Knockeen | Alliance |
| 12.12.2023 07:00 | MXCT | CEO Transition and Revenue Guidance Update | RNS |
| 07.12.2023 09:50 | MXCT | Exercise of options and PDMR dealing | RNS |
| 04.12.2023 07:00 | MXCT | Exercise of options and PDMR dealing | RNS |
| 01.12.2023 17:43 | MXCT | Total Voting Rights | RNS |
| 30.11.2023 07:00 | MXCT | Exercise of options and PDMR dealing | RNS |
| 17.11.2023 07:00 | MXCT | Exercise of options and PDMR dealing | RNS |
| 16.11.2023 13:05 | MXCT | MaxCyte Joins the Alliance for mRNA Medicines | Reach |
| 09.11.2023 14:14 | VOD, ZEG, DSW | EARNINGS AND TRADING: Chapel Down hopes to make splash on AIM | Alliance |
| 09.11.2023 07:01 | MXCT | Filing of Form 10-Q | RNS |
| 09.11.2023 07:00 | MXCT | Third Quarter Results | RNS |
| 07.11.2023 07:00 | MXCT | Participation in Upcoming Investor Conferences | RNS |
| 01.11.2023 15:44 | TMO, SNWS, STB | UK earnings, trading statements calendar - next 7 days | Alliance |
| 01.11.2023 13:12 | MXCT | Total Voting Rights | RNS |
| 05.10.2023 10:16 | TAVI, HE1, MXCT | AIM WINNERS & LOSERS: SDX Energy receives gas prepayment from Citic | Alliance |
| 05.10.2023 10:08 | MXCT | MaxCyte shares fall as warns of sharp revenue drop, citing volatility | Alliance |
| 02.10.2023 16:03 | MXCT | Total Voting Rights | RNS |
| 13.09.2023 14:28 | MXCT | TR-1: Notification of major holdings | RNS |
| 12.09.2023 13:21 | MXCT | TR-1: Notification of major holdings | RNS |
| 06.09.2023 13:05 | MXCT | Appointment of Executive VP of Bioprocessing | Reach |
| 05.09.2023 16:17 | MXCT | TR-1: Notification of major holdings | RNS |
| 05.09.2023 13:05 | MXCT | Baird Global Healthcare Conference Participation | RNS |
| 04.09.2023 13:32 | MXCT | TR-1: Notification of major holdings | RNS |
| 04.09.2023 07:00 | MXCT | Total Voting Rights | RNS |
| 01.09.2023 09:01 | MXCT | Exercise of options and PDMR dealing | RNS |
| 18.08.2023 17:25 | MXCT | TR-1 | RNS |
| 17.08.2023 16:27 | MXCT | TR-1: Notification of major holdings | RNS |
| 17.08.2023 07:00 | MXCT | TR-1: Notification of Major Holdings | RNS |
| 10.08.2023 10:22 | MXCT | MaxCyte shares fall as revenue plummets in first half, loss widens | Alliance |
| 10.08.2023 07:25 | MXCT | Filing of Form 10-Q | RNS |
| 10.08.2023 07:00 | MXCT | Second Quarter and Half-Year Results | RNS |
| 08.08.2023 15:15 | MXCT | TR-1: Notification of major holdings | RNS |
| 07.08.2023 17:01 | MXCT | Total Voting Rights and Block Listing Return | RNS |
| 02.08.2023 15:46 | EGY, TUI, TCAP | UK earnings, trading statements calendar - next 7 days | Alliance |
| 01.08.2023 14:26 | PALM, CNC, MXCT | TRADING UPDATES: MaxCyte strikes deal; Barkby sells Workshop | Alliance |
| 01.08.2023 13:05 | MXCT | Strategic Platform License with Prime Medicine | RNS |
| 31.07.2023 17:26 | MXCT | Exercise of options and PDMR dealing | RNS |
| 26.07.2023 14:31 | MXCT | TR-1: Notification of major holdings | RNS |
| 24.07.2023 17:08 | MXCT | TR-1: Notification of major holdings | RNS |
| 24.07.2023 17:06 | MXCT | TR-1: Notification of major holdings | RNS |
| 13.07.2023 13:05 | MXCT | Notice of Second Quarter 2023 Financial Results | RNS |
